4.6 Article

Comorbidities in osteoarthritis (ComOA): a combined cross-sectional, case-control and cohort study using large electronic health records in four European countries

Journal

BMJ OPEN
Volume 12, Issue 4, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2021-052816

Keywords

EPIDEMIOLOGY; Musculoskeletal disorders; RHEUMATOLOGY

Funding

  1. Foundation for Research in Rheumatology (FOREUM)
  2. Swedish Research Council [2020-01103]
  3. Governmental funding of clinical research within the national health services (ALF)
  4. Swedish Rheumatism Association
  5. National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands
  6. National Institute for Health Research (NIHR) School for Primary Care Research
  7. National Institute for Health Research (NIHR) Research Professorship in General Practice [NIHR-RP-2014-04-026]
  8. Vinnova [2020-01103] Funding Source: Vinnova
  9. Swedish Research Council [2020-01103] Funding Source: Swedish Research Council

Ask authors/readers for more resources

This paper describes a multinational study conducted in the UK, Netherlands, Sweden, and Spain to explore comorbidities in people with osteoarthritis (OA). The study aims to investigate the temporal associations, clusters and trajectories of comorbidities, the role of analgesics in incidence of comorbidities, potential biomarkers and causality between OA and comorbidities, and variations between countries. The study will use case-control and cohort designs, as well as analysis techniques such as latent class analysis and Mendelian randomization. Results will be disseminated through various channels.
Introduction Osteoarthritis (OA) is one of the leading chronic conditions in the older population. People with OA are more likely to have one or more other chronic conditions than those without. However, the temporal associations, clusters of the comorbidities, role of analgesics and the causality and variation between populations are yet to be investigated. This paper describes the protocol of a multinational study in four European countries (UK, Netherlands, Sweden and Spain) exploring comorbidities in people with OA. Methods and analysis This multinational study will investigate (1) the temporal associations of 61 identified comorbidities with OA, (2) the clusters and trajectories of comorbidities in people with OA, (3) the role of analgesics on incidence of comorbidities in people with OA, (4) the potential biomarkers and causality between OA and the comorbidities, and (5) variations between countries. A combined case-control and cohort study will be conducted to find the temporal association of OA with the comorbidities using the national or regional health databases. Latent class analysis will be performed to identify the clusters at baseline and joint latent class analysis will be used to examine trajectories during the follow-up. A cohort study will be undertaken to evaluate the role of non-steroidal anti-inflammatory drugs (NSAIDs), opioids and paracetamol on the incidence of comorbidities. Mendelian randomisation will be performed to investigate the potential biomarkers for causality between OA and the comorbidities using the UK Biobank and the Rotterdam Study databases. Finally, a meta-analyses will be used to examine the variations and pool the results from different countries. Ethics and dissemination Research ethics was obtained according to each database requirement. Results will be disseminated through the FOREUM website, scientific meetings, publications and in partnership with patient organisations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available